Our Pharmaceutical Director, Dr Gerry Kenna, recently presented a virtual seminar on “In vitro models for assessment of drug-induced liver injury (DILI): a personal perspective” to the Liver Toxicity Working Group of the US regulator, the FDA
Archives: Videos
Lecture by Pandora Pound
Presentation: Ending animal testing to advance human relevant research via New Approach Methodologies’
Rebecca Ram was invited to give a presentation on the issues concerning use of animals in research at a recent workshop hosted by Advocates for Animals, the UK’s first legal organisation devoted to animal protection.
Breaking the lock-in to animal research within academia
Our Research Consultant, Dr Pandora Pound is speaking this afternoon at the 11th World Congress on Alternatives and Animal Use in the Life Sciences, on “Breaking the lock-in to animal research within academia”.
New Approach Methodologies Funding and Regulation
Our Scientific Consultant, Rebecca Ram, spoke at the 11th World Congress on Alternatives and Animal Use in the Life Sciences on “New Approach Methodologies Funding and Regulation”.
Overcoming data availability obstacles in the way of evidence-based toxicology
In a recent webinar our Director Dr Jan Turner, described why gaps in this data either through selective reporting or omission of significant data all together, can have profound effects on the decision-making of regulatory agencies and ultimately lead to unsafe drugs being placed on the market.
Developing Methods and Technologies to Ensure Safe and Effective Medicines
“The future of medicines regulation in the UK” was the subject of a recent Westminster Health Forum meeting at which our Director, Dr Jan Turner described why innovation and the development of methods to ensure safe and effective medicines, is imperative for the UK. See the presentation here.
Current regulatory guidelines and technological development of 3D models: Closing the gap
Presentation by Dr Jan Turner
Continue reading “Current regulatory guidelines and technological development of 3D models: Closing the gap”
Developing Methods and Technologies to Ensure Safe and Effective Medicines
“The future for UK regulation of medicines, medical devices and clinical trials – transparency and public trust, safety and enforcement, and support for innovation” was the subject of a recent Westminster Health Forum meeting at which our Director, Dr Jan Turner described why innovation and the development of methods to ensure safe and effective medicines, is imperative for the UK now and importantly, post Brexit.
Human relevant science to understand and treat COVID-19
Hosted by the Physicians Committee for Responsible Medicine, in conjunction with US Congresswoman Lucille Roybal-Allard, our Pharmaceutical Director, Dr Gerry Kenna, recently spoke on why “Human-relevant models are needed to understand and treat human COVID-19 disease” at PCRM’s Congressional hearing “Confronting COVID-19: A Briefing on Prioritizing Human-Based Research”. A recording of the event is here and Dr Kenna’s slides are here.
Lecture by Pandora Pound for course: Animals in Research: Law, Policy, and Humane Sciences
2020: Lecture by Pandora Pound for course: Animals in Research: Law, Policy, and Humane Sciences, at Johns Hopkins Bloomberg School of Public Health, US See details of whole course here and slides for lecture by Pandora Pound here: animals-lec11
Human Relevant In Vitro Models: Barriers, Initiatives and Progress Towards Replacing Animal Methods in Drug Discovery
Hear our Director Dr Jan Turner speak about barriers and progress to adoption of human relevant in vitro models in drug discovery at the Advances in Cell and Tissue Culture conference in Cardiff, June 2019
Kathy Archibald speaking via Skype to the Institute of Bioethics
Kathy Archibald speaking via Skype to the Institute of Bioethics at the Pontificia University Javeriana in Bogotá, Colombia. Many thanks to Professor Javier Andrés González Cortés.
The prediction of human hazard using in vitro data
See our Pharmaceutical Director, Dr Gerry Kenna, present on the prediction of human hazard using in vitro data at the British Toxicological Society (BTS) Annual Congress, Cambridge UK, 17th April 2019.
Dr Jan Turner speaking at the March 8th 2019 London Conference
Dr Jan Turner speaking at the March 8th 2019 London Conference to launch the book:
Overcoming obstacles to human-relevant science
Dr Gerry Kenna speaking on: “Overcoming obstacles to human-relevant science.” WIST 2nd Congress: Science instead of animals. Cologne, Germany, October 27, 2018
- View 30 minute talk
- View slides
- View programme
- Read all abstracts and view all talks in English and German
Humanising Drug Safety Testing
Declaration of Lisbon
At the International Conference of Alternatives to Animal Experimentation in Portugal, on 8th May 2015, Dr Philip Low presented – to unanimous support – the ‘Declaration of Lisbon‘:
Dr Bob Coleman, UK Science Director of Safer Medicines Trust, also spoke at the Conference on ‘Humanising Drug Safety Testing’ – view his presentation
